Precision Biosciences (DTIL) Cash from Operations (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.11% |
| Dec 31, 2025 | 26.33% |
| Sep 30, 2025 | 24.67% |
| Jun 30, 2025 | -6.40% |
| Mar 31, 2025 | -1.98% |
| Dec 31, 2024 | -216.02% |
| Sep 30, 2024 | 60.24% |
| Jun 30, 2024 | 21.66% |
| Mar 31, 2024 | -125.35% |
| Dec 31, 2023 | 63.53% |
| Sep 30, 2023 | -9.27% |
| Jun 30, 2023 | 32.83% |
| Mar 31, 2023 | -44.05% |
| Dec 31, 2022 | -174.84% |
| Sep 30, 2022 | 220.48% |
| Jun 30, 2022 | 16.10% |
| Mar 31, 2022 | -21.92% |
| Dec 31, 2021 | 0.94% |
| Sep 30, 2021 | 23.72% |
| Jun 30, 2021 | -146.04% |
| Mar 31, 2021 | 606.04% |
| Dec 31, 2020 | 39.47% |
| Sep 30, 2020 | 13.87% |
| Jun 30, 2020 | 0.42% |
| Mar 31, 2020 | -26.05% |
| Dec 31, 2019 | -47.07% |
| Sep 30, 2019 | 15.67% |
| Jun 30, 2019 | 16.74% |
| Mar 31, 2019 | -54.17% |
| Dec 31, 2018 | 14.19% |
| Sep 30, 2018 | -61.62% |
| Jun 30, 2018 | 35.59% |